Activation of 5-HT(2A/2C) receptors within the nucleus accumbens increases local dopaminergic transmission

Brain Research Bulletin

Volumn 51, Issue 1, 2000, Pages 75-81

  Yan, Qing Shan ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

( ) 1 (4 Iodo 2; 5 dimethoxyphenyl) 2 aminopropane (DOI); 857; Dopamine; Ketanserin; LY 53; Microdialysis; Nucleus accumbens

Indexed keywords

1 ISOPROPYL 6 METHYLERGOLINE 8 CARBOXYLIC ACID 2 HYDROXY 1 METHYLPROPYL ESTER; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; FANANSERIN; KETANSERIN; RECEPTOR SUBTYPE; RITANSERIN; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; 4-IODO-2,5-DIMETHOXYPHENYLISOPROPYLAMINE; AMPHETAMINE DERIVATIVE; DOPAMINE; ERGOLINE DERIVATIVE; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SODIUM CHANNEL BLOCKING AGENT; TETRODOTOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; ANIMAL; DRUG EFFECT; KINETICS; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; SYNAPTIC TRANSMISSION;

AMPHETAMINES; ANIMALS; DOPAMINE; ERGOLINES; KETANSERIN; KINETICS; MALE; MICRODIALYSIS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SODIUM CHANNEL BLOCKERS; SYNAPTIC TRANSMISSION; TETRODOTOXIN;

EID: 0033621680     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(99)00208-7     Document Type: Article

References (43)

1. 1C receptors in rat brain. J. Pharmacol. Exp. Ther. 255:1990;843-857.
2. 2-antagonist. Drug Dev. Res. 6:1985;263-300.
3. Bardo M.T. Neuropharmacological mechanisms of drug reward Beyond dopamine in the nucleus accumbens . Crit. Rev. Neurobiol. 12:1998;37-67.
4. Blackburn J.R., Pfaus J.G., Phillips A.G. Dopamine functions in appetitive and defensive behaviours. Prog. Neurobiol. 39:1992;247-279.
5. Campbell A.D., McBride W.J. Serotonin-3 receptor and ethanol-stimulated dopamine release in the nucleus accumbens. Pharmacol Biochem Behav. 51:1995;835-842.
6. 3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res. 543:1991;354-357.
7. 2 receptor antagonist, LY53857. Drug Dev. Res. 5:1985;313-321.
8. 2 receptor antagonist, ritanserin, on biogenic amines in the rat nucleus accumbens. Eur. J. Pharmacol. 192:1990;427-442.
9. Devaud L.L., Hollingsworth E.B., Cooper B.R. Alterations in extracellular and tissue levels of biogenic amines in rat brain induced by the serotonin-2 receptor antagonist, ritanserin. J. Neurochem. 59:1992;1459-1466.
10. 2C/2B receptors enhances dopamine release in the rat nucleus accumbens. Neuropharmacology. 37:1998;265-272.
11. 2 receptors through the rat central nervous system using quantitative autoradiography. Brain Res. 421:1987;263-279.
12. Guan X.M., McBride W.J. Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release. Brain Res. Bull. 23:1989;541-547.
13. Gobert A., Millan M.J. Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats. Neuropharmacology. 38:1999;315-317.
14. 1B/1D receptors on dopamine release in the guinea pig nucleus accumbens A microdialysis study . Neurosci. Lett. 225:1997;57-60.
15. Hoyer D., Martin G. 5-HT receptor classification and nomenclature Towards a harmonization with the human genome . Neuropharmacology. 36:1997;419-428. (review).
16. Humphrey P.P.A., Hartig P., Hoyer D. A proposed new nomenclature for 5-HT receptors. Trends Pharmacol. Sci. 14:1993;233-236.
17. Hyman S.E. Addiction to cocaine and amphetamine. Neuron. 16:1996;901-904.
18. Koob G.F., Robert A.J., Schulteis G., Parsons L.H., Heyser C.J., Hyytia P., Merlo-Pich E., Weiss F. Neurocircuitry targets in ethanol reward and dependence. Alcohol. Clin. Exp. Res. 22:1998;3-9.
19. Koob G.F. Drugs of abuse Anatomy, pharmacology and function of reward pathway . Trends Pharmacol. Sci. 13:1992;177-184.
20. Le Moal M., Simon H. Mesocorticolimbic dopaminergic network Functional and regulatory roles . Physiol. Rev. 71:1991;155-234.
21. 2 receptor antagonist. In vitro and ex vivo selectivity profile. Eur. J. Pharmacol. 233:1993;29-35.
22. Meltzer H.Y. Clinical studies on the mechanism of action of clozapine The dopamine-serotonin hypothesis of schizophrenia . Psychopharmacology. 99:1989;S18-S27.
23. Moore R.Y., Halaris A.E., Jones B.E. Serotonin neurons in the midbrain raphe Ascending projections . J. Comp. Neurol. 180:1978;417-438.
24. 2 receptors in the rat brain. Neuroscience. 54:1993;701-717.
25. 2 receptor blockade by amperozide suppress ethanol drinking in genetically preferring (P) rats. Pharmacol. Biochem. Behav. 45:1993;741-747.
26. Nakahara K., Yokoo H., Yoshida M., Tanaka M., Shigemori M. Effect of nitric oxide on central dopamine neurons. Brain Nerve. 46:1994;1147-1153.
27. Nissbrandt H., Waters N., Hjorth S. The influence of serotonergic drugs on dopaminergic neurotransmission in rat substantia nigra, striatum and limbic forebrain in vivo. Naunyn-Schmiedebergs Arch. Pharmacol. 346:1992;12-19.
28. 2 receptors to decrease potassium conductance in rat nucleus accumbens neurons. J. Physiol. 417:1989;1-12.
29. Oades R.D., Halliday G.M. Ventral tegmental (A10) system Neurobiology. 1. Anatomy and connectivity . Brain Res. Rev. 12:1987;117-165.
30. Panocka I., Massi M. Long-lasting suppression of alcohol preference in rats following serotonin receptor blockade by ritanserin. Brain Res. Bull. 28:1992;493-496.
31. Parsons L.H., Justice J.B. Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res. 606:1993;195-199.
32. Paxinos G., Watson C. The rat brain in stereotaxic coordinates, 2nd ed. 1986;Academic Press, New York.
33. Pessia M., Jiang Z.G., North R.A., Johnson S.W. Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro. Brain Res. 654:1994;324-330.
34. Prisco S., Pagannone S., Esposito E. Serotonin-dopamine interaction in the rat ventral tegmental area An electrophysiological study in vivo . J. Pharmacol. Exp. Ther. 271:1994;83-90.
35. 2A receptor blockade . J. Pharmacol. Exp. Ther. 277:1996;1541-1549.
36. 2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition. Psychopharmacology. 98:1989;45-50.
37. Vertes R.P., Martin G.F. Autoradiographic analysis of ascending projections from the pontine and mesencephalic reticular formation and the median raphe nucleus in the rat. J. Comp. Neurol. 275:1988;511-541.
38. Weiss F., Lorang M.T., Bloom F.E., Koob G.F. Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens Genetic and motivational determinants . J. Pharmacol. Exp. Ther. 267:1993;250-267.
39. West A.R., Galloway M.P. Intrastriatal infusion of (±)-S-nitroso-N-acetylpenicillamine releases vesicular dopamine via an ionotropic glutamate receptor-mediated mechanism. An in vivo microdialysis study in chloral hydrate-anesthetized rats. J. Neurochem. 66:1996;1971-1980.
40. West A.R., Galloway M.P. Nitric oxide and potassium chloride-facilitated striatal dopamine efflux in vivo Role of calcium-dependent release mechanisms . Neurochem. Int. 33:1999;493-501.
41. Westerink B.H.C., Tuntler J., Damsma G., Rollema H., de Vries J.B. The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis. Naunyn-Schmiedebergs Arch. Pharmacol. 336:1987;502-507.
42. 2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens. Brain Res. 781:1998;291-299.
43. Yoshimoto K., McBride W.J. Regulation of nucleus accumbens dopamine release by the dorsal raphe nucleus in the rat. Neurochem. Res. 17:1992;401-407.